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Introduction: Clostridium difficile infection causes severe diarrhea, abdominal pain and weight loss. A course of
metronidazole is the initial treatment; however up to 40% of patients have at least one recurrence. Some patients
have recurrent infections requiring further treatment with vancomycin, others need multiple courses of expensive
treatment. Fecal transplantation has been proposed as an effective treatment option for patients with recurrences.
We report the case of a patient with recurrent Clostridium difficile infection unresponsive to usual treatment and her
experience with home fecal transplantation.
Case presentation: A 66-year-old Canadian Caucasian woman presented to her family doctor in December 2012
with a 10-day history of explosive watery diarrhea. She was diagnosed with Clostridium difficile infection and treated
with metronidazole. Diarrhea recurred and despite treatment with vancomycin and finally, fidaxomicin, she continued
to have recurrent Clostridium difficile infection over the following four months. A formal fecal transplantation program
was not available in her home province; therefore home fecal transplantation was performed under supervision by her
family physician. This was the first case of fecal transplantation performed in the province and was done outside of a
hospital setting. She recovered immediately and has been well for the past year since the procedure.
Conclusions: Home fecal transplantation by rectal enema is a viable, safe and practical option for patients with
recurrent Clostridium difficile infection. It is less costly and uses fewer resources than traditional delivery methods
through nasogastric tube, upper endoscopy or colonoscopy. Patients and their families and donors need medical
supervision through the process of screening, telephone availability during the procedure and medical follow-up.
This can be done by family physicians without the need for expensive hospital care and subsequent follow-up.
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Clostridium difficile infection (CDI) causes severe diarrhea,
abdominal pain and weight loss. A course of metronidazole
is the recommended initial treatment; however, up to 40%
of patients have at least one recurrence [1]. Some patients
have recurrent infections requiring further treatment with
vancomycin, others need multiple courses of expensive
treatment. Fecal transplantation has been proposed as an
effective treatment option for patients with recurrences.
Here we report the case of a patient with recurrent CDI
unresponsive to usual treatment and her experience with
home fecal transplantation.* Correspondence: pduke@mun.ca
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A 66-year-old Canadian Caucasian woman presented to
her family doctor in December 2012 with a 10-day his-
tory of explosive watery diarrhea. This was accompanied
by an initial fever and chills for two days, abdominal
cramping, nausea and poor appetite but no rectal bleed-
ing. There had been an 8kg weight loss over the previous
four months. There was no history of recent travel or in-
fectious contacts; however she had made weekly visits to
a nursing home for some months prior. Amoxicillin was
prescribed for a dental infection four months previously.
Approximately 14 months and again at nine months
prior to this present episode, she had bouts of diarrhea
lasting about one week. Past medical and family history
was noncontributory. Medications included atorvastatin
and diclofenac sodium/misoprostol. She looked thin and
her examination showed normal vital signs, no fever andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 List of screening tests for potential donors and
recipients prior to fecal transplantation
Screening type
Screening serology (donor) Human immunodeficiency virus (HIV)
Human T-lymphotropic virus I/II
Syphilis enzyme immunoassay
Hepatitis A immunoglobulin M
Hepatitis B surface antigen
Hepatitis C antibody
Helicobacter pylori antibody
Screening serology (recipient) Complete blood count














List from Silverman et al. [1].
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quadrant. A further general physical exam was negative
for other sources of infection. Lab investigations showed
normal results for complete blood count, electrolytes,
blood urea nitrogen, creatinine, estimated glomerular
filtration rate, glucose and liver function. Stools for culture
and sensitivity and C. difficile toxin were requested. The
differential diagnosis included an infectious etiology,
inflammatory bowel disease or CDI. Ciprofloxacin and
metronidazole were started but ciprofloxacin was dis-
continued following a negative sigmoidoscopy and positive
C. difficile toxin test result the following day. Metronidazole
was continued for 10 days along with probiotics, but severe
diarrhea returned three days after finishing. Severe diarrhea
recurred despite further treatment with vancomycin. Her
repeat blood tests were normal apart from an increased
serum calcium level of 2.7mmol/L (normal range: 2.10 to
2.55mmol/L). Her repeat C. difficile toxin test was again
positive. Fidaxomicin 200mg orally twice a day was pre-
scribed for 10 days, however symptoms recurred. Vanco-
mycin was restarted while arrangements were investigated
for out-of-province treatment with fecal transplantation.
Our patient and her husband asked their family doc-
tor about home fecal transplantation, and had with
them a copy of a journal article on home fecal trans-
plantation by Silverman et al. [1]. The family doctor
contacted the lead author by phone for further discus-
sion and details about the procedure. Our patient’s
healthy daughter was selected as donor, and her husband
was screened in the event that another donor was required.
Screening tests suggested by Silverman et al. are listed in
Table 1.
Home fecal transplant, using the protocol recommended
by Silverman et al. [1], was done within a week, with
the assistance of our patient’s husband and daughter.
Vancomycin was stopped for 48 hours prior to the proced-
ure and Saccharomyces boulardii was taken during the
transplant and for 60 days after. Donor stool in the amount
of 50ml, obtained immediately prior to the procedure, was
added to 200ml of normal saline in a blender. The contents
were blended to a ‘milkshake’ consistency and emptied into
an enema bag. The mixture was administered by her family
and she lay supine on her left side for five hours afterwards
to prevent defecation.
Diarrhea recurred and so the transplant was repeated
on day three, with her lying supine for seven hours (two
hours longer than with the previous procedure). The diar-
rhea was resolved immediately, however both our patient
and her family decided to repeat the transplant using her
husband as the donor two weeks later when the symptoms
returned. There was immediate resolution of the diarrhea
with no further recurrence of symptoms. Her appetite and
energy returned and she had gained 15lbs two months
after the transplant.She underwent further investigations for hypercalcemia
during this time and subsequently underwent a parathy-
roidectomy for removal of a parathyroid adenoma.
Discussion
CDI is thought to result from the use of antibiotics that
alter normal bowel flora which allows infection with
pathogenic strains of C. difficile [2]. Exposure to a health-
care setting, the use of gastric acid-suppressing medications
and underlying bowel conditions have all been established
as potential risk factors [3]. In the United States, the in-
cidence of CDI tripled between 1996 and 2005 (31 per
100,000 versus 84 per 100,000). There has also been an
increase in disease severity, with mortality rates of up
to 6.9% [4]. Failure rates with metronidazole treatment
have risen from 2.5% to more than 18% since 2000 [4].
Patients older than 65 have a recurrence rate of up to 50%,
increasing to greater than 60% after two episodes [4]. Many
patients require multiple courses of antibiotics such as
metronidazole and vancomycin. Fidaxomicin, an additional
treatment option, is extremely costly. Hence, clinicians are
interested in finding alternative treatments which are more
successful and less expensive for the patient.
Fecal transplantation or fecal bacteriotherapy was first
documented in 1958 [2]. The procedure involves trans-
plantation of donor stool to the affected patient by various
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catheter or enema to repopulate the bowel with normal
flora. The literature suggests that fecal transplantation
has an extremely high cure rate, with recent systematic
reviews reporting resolution of symptoms that ranged
from 81 to 93% depending on the site and method of
administration [5,6]. Procedures where donors were family
members had a higher success rate than nonrelated donors
(93 versus 84%) [2], and procedures administering donor
feces to the cecum and distal colon have a higher cure rate
than the duodenum, stomach or jejunum (93 versus 81 to
86%) [5].
A Canadian study by Kassam et al. reviewed 27 patients
with recurrent CDI treated with fecal transplantation by
retention enema [4]. In this series, 93% of patients had
resolution of their symptoms and five patients needed a
second transplant due to recurrence, with three of these
having full resolution. There were no adverse events or
complications associated with the procedure. Another
Canadian study by Silverman et al. followed seven patients
who had self-administered home fecal transplantation.
Patients ranging in age from 30 to 88-years-old had re-
current CDI, with the initial infection occurring in hos-
pital. All donors were family members. The procedure
was carried out by the patient or family members and all
patients had resolution of CDI [1]. In a follow-up system-
atic review and meta-analysis, Kassam et al. found that
lower gastrointestinal delivery of fecal transplant (for
example by enema or colonoscopy) has a higher resolution
rate than upper gastrointestinal delivery (for example
nasogastric or nasojejunal tube or gastroscopy) (Table 2) [6].
Our patient was very accepting of home fecal transplant-
ation as there was no formal fecal transplantation program
in the province. She had the help of family to administer
the procedure and to be donors. They reported that, in
their experience, it would be impossible for a patient to
carry out the procedure without help from family or
friends. Patients and families need help in obtaining the
small amount of equipment needed and need medical
supervision and support throughout the process, tele-
phone availability during the procedure and medical
follow-up.
Home fecal transplantation is less costly than multiple
courses of expensive drugs. There may be fewer adverseTable 2 Resolution rate for Clostridium difficile infection
treated with fecal transplant by method of delivery





Upper gastrointestinal delivery (nasogastric or
nasojejunal tube, gastroscopy, gastrostomy tube)
42/51 (82.3%)
Adapted from Kassam et al. [6].effects [7] and less use of hospital resources with rectal
enema than delivery through nasogastric tube, endoscopy
or colonoscopy. Health authorities may consider using
rectal enemas in a home or hospital-based fecal trans-
plantation program for patients who would find it difficult
to carry out this procedure on their own at home.
Our patient found the article by Silverman et al. [1]
online in a search for alternatives to treat her recurrent
severe CDI. This highlights the importance of patients’
participation and autonomy in their own care and the need
for patient-centered care in the medical care of patients
and their families.
We do not have a fecal transplantation program avail-
able in our home province of Newfoundland and Labrador
(population of 526,000) in Canada. The closest program
is in Ontario, over 3000 kilometers from Newfoundland.
Newfoundland is an island; seeking treatment in Ontario
would entail great travel and accommodation costs for her
and her husband, as well as extreme discomfort when still
feeling very ill from the infection. By doing this procedure
at home by rectal enema, we prevented out-of-province
travel and further costs for our patient.
Conclusions
Home fecal transplantation by rectal enema is a viable, safe
and practical option for patients with recurrent CDI. It
is less costly and uses fewer resources than traditional
delivery methods through nasojejunal tube, upper endos-
copy or colonoscopy. Patients and their families and
donors need medical supervision throughout the process
of screening, telephone availability during the procedure
and medical follow-up.
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